Font Size: a A A

Experimental Study On Anti-Angiogenic Effect Of Low-Dose Metronomic Chemotherapy With Cisplatin

Posted on:2010-03-31Degree:MasterType:Thesis
Country:ChinaCandidate:K MuFull Text:PDF
GTID:2144360275464166Subject:Oncology
Abstract/Summary:PDF Full Text Request
Objective To study anti-angiogenic effect of low-dose metronomic chemotherapy with cisplatin in vitro and vivo.Methods①We use MTT method to observe the influence of low-dose metronomic chemotherapy with cisplatin on HUVECs and HepG2 proliferation.②The H22 cells of liver carcinoma were injected subcutaneously into KM mice.The mice accepted low-dose metronomic(LDM) chemotherapy with cisplatin(LDM:cisplatin 0.6mg/(kg.d)every day and continually for five days in one week) or maximum tolerated dose(MTD) chemotherapy with cisplatin(MTD:cisplatin 9mg/(kg.d) once).Then,We use immunohistochemical method to detected the expression of EGFR in tumors.③Chick embryo chorioallantoic membrane(CAM) model was used to check the inhibitory effect of low-dose metronomic chemotherapy with cisplatin on neovascularization in vivo:chick embryo were randomized into 5 groups(12 in every group) and incubated for 9 days.The CAM was treated with cisplatin by different doses for 3 days.The density of blood vessel of CAM was counted under microscope.Results①The continuous low-dose cisplatin(0.3~1.2μg/ml) could inhibit the prolifetation of HUVECs and the inhibited effect was dose-dependent and time-dependent(F=14.00~206.80, q=2.18~39.63,P<0.05).Furthermore,experiments of inhibition of proliferation on HepG2 showed that low-dose cisplatin was ineffective(F=0.51~0.79,q=0.47~1.54,P>0.05).②The expression of EGFR decreased significantly in the mice received LDM cisplatin therapy compared with those in control group and MTD cisplatin therapeutic group(F=140.67,q=4.17~22.31,P<0.05).③The continuous low-dose cisplatin could suppress angiogenesis of CAM in vivo:Compared with physiological saline group,angiogenesis on CAM in low-dose cisplatin groups had heavy inhibition,accompanied by the decreased density of vessels(F=184.44,q=3.18~36.37,P<0.05) with inhibitory rate of 30.87~60.61%.Conclusion Low-dose metronomic chemotherapy with cisplatin(non-cytotoxic concentration) has anti-angiogenic ability in vivo and in vitro.The effect of anti-angiogenesis may be correlated with the inhibition growth of the blood vessel endothelial cells and the decrease expression of EGFR.
Keywords/Search Tags:Cisplatin, Metronomic chemotherapy, Angiogenesis, HUVEC, EGFR
PDF Full Text Request
Related items